SeaStar Medical Holding Corp [NASDAQ: ICU] stock went on an upward path that rose over 1.99% on Wednesday, amounting to a one-week price increase of more than 2.68%. The company report on February 1, 2024 at 8:30 AM that SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology.
“A significant opportunity exists to improve treatment of dysregulated hyperinflammatory response that can cause multiorgan damage and even death. The SCD is an innovative and proven approach that selectively targets highly active inflammatory cells to quell the hyperinflammatory response resulting from a range of conditions, and potentially reverse organ injury,” said Eric Schlorff, CEO of SeaStar Medical.
Over the last 12 months, ICU stock dropped by -81.02%. The one-year SeaStar Medical Holding Corp stock forecast points to a potential upside of 59.0. The average equity rating for ICU stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $53.66 million, with 65.15 million shares outstanding and 45.70 million shares in the current float. Compared to the average trading volume of 3.46M shares, ICU stock reached a trading volume of 3761188 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on SeaStar Medical Holding Corp [ICU]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ICU shares is $2.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ICU stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
ICU Stock Performance Analysis:
SeaStar Medical Holding Corp [ICU] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.68. With this latest performance, ICU shares gained by 43.80% in over the last four-week period, additionally plugging by 85.89% over the last 6 months – not to mention a drop of -81.02% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ICU stock in for the last two-week period is set at 64.99, with the RSI for the last a single of trading hit 65.28, and the three-weeks RSI is set at 62.73 for SeaStar Medical Holding Corp [ICU]. The present Moving Average for the last 50 days of trading for this stock 0.5808, while it was recorded at 0.8107 for the last single week of trading, and 0.6173 for the last 200 days.
Insight into SeaStar Medical Holding Corp Fundamentals:
SeaStar Medical Holding Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.18 and a Current Ratio set at 0.18.
SeaStar Medical Holding Corp [ICU] Institutonal Ownership Details
The top three institutional holders of ICU stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2815%. BLACKROCK INC., holding 1.03 billion shares of the stock with an approximate value of $176.59 billion in ICU stocks shares; and BERKSHIRE HATHAWAY INC, currently with $156.75 billion in ICU stock with ownership which is approximately 5.8325%.
